SILBERMAN DAVID (Chief Financial Officer) received a stock award from ORAMED PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/20/2023ACC: 0001209191-23-024936
Officer· Chief Financial Officer
Since Jul 2021
+97.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
97.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+97.50K
Price / share
—
Trade value
—
% of position
90.3%
4/17/2023
108K→205.50K
Total
Net shares
+97.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/17/2023 | A · Award | +97.50K | — | — | 90.3% | 108K | 205.50K |
| Total | +97.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported